Exploration of key pathogenic mechanisms and potential intervention targets of the traditional Chinese medicine Coptis chinensis in the treatment of cervical cancer based on network pharmacology and molecular docking techniques
Authors:
Open Access
- 1 January 2025
- journal article
- Published by AME Publishing Company in Translational Cancer Research
- Vol. 14 (1) , 626-639
Abstract
Background: Traditional Chinese medicine (TCM) has shown potential in the treatment of cancer. This study investigated the molecular targets and mechanisms of Coptis chinensis in the treatment of cervical cancer using network pharmacology and bioinformatics. Methods: Effective Coptis chinensis components were screened from the Traditional Chinese Medicine Systems Pharmacology (TCMSP) platform based on the following criteria: drug-like properties (DLP) ≥0.18 and oral bioavailability (OB) ≥30%. Target genes were identified through DrugBank, while differentially expressed genes (DEGs) related to cervical cancer were sourced from the Gene Expression Omnibus (GEO) database (GSE7803) based on the following criteria: |log fold change| >2 and PResults: In total, 10 effective Coptis chinensis compounds and 181 target genes were identified from the TCMSP database. The GEO analysis of GSE7803 identified 109 DEGs. The Venn diagram analysis identified the following seven shared DEGs: AR, MAOB, CDKN2A, TOP2A, CXCL8, matrix metalloproteinase 1 (MMP1), and SPP1. MMP1 and SPP1 were confirmed to be upregulated candidate genes in cervical cancer tissues, and to be associated with a worse prognosis [overall survival (OS), disease-specific survival (DSS), and progression-free interval (PFI), PMMP1 expression was significantly decreased in the peripheral blood of patients receiving conventional chemotherapy and Coptis chinensis compared to those receiving chemotherapy alone. Multivariate Cox regression confirmed that high MMP1 expression and a lack of Coptis chinensis treatment were independent risk factors for a poor prognosis (PConclusions: MMP1 could be a predictive biomarker for cervical cancer. Coptis chinensis may exert therapeutic effects through MMP1 regulation via multiple pathways. Our findings provide a theoretical foundation for the clinical application of MMP1.Keywords
This publication has 24 references indexed in Scilit:
- Anti-cervical cancer effects of Compound Yangshe granule through the PI3K/AKT pathway based on network pharmacologyJournal of Ethnopharmacology, 2022
- Network pharmacology: curing causal mechanisms instead of treating symptomsTrends in Pharmacological Sciences, 2022
- Berberine Phospholipid Is an Effective Insulin Sensitizer and Improves Metabolic and Hormonal Disorders in Women with Polycystic Ovary Syndrome: A One-Group Pretest–Post-Test Explanatory StudyNutrients, 2021
- Effects of Quercetin on the Efficacy of Various Chemotherapeutic Drugs in Cervical Cancer CellsDrug Design, Development and Therapy, 2021
- TCM network pharmacology: A new trend towards combining computational, experimental and clinical approachesChinese Journal of Natural Medicines, 2021
- GDF15 knockdown suppresses cervical cancer cell migration in vitro through the TGF‐β/Smad2/3/Snail1 pathwayFEBS Open Bio, 2020
- Activating transcription factor 6 regulated cell growth, migration and inhibiteds cell apoptosis and autophagy via MAPK pathway in cervical cancerJournal of Reproductive Immunology, 2020
- Identification of MMP1 as a Potential Prognostic Biomarker and Correlating with Immune Infiltrates in Cervical Squamous Cell CarcinomaDNA and Cell Biology, 2020
- Quercetin modifies 5′CpG promoter methylation and reactivates various tumor suppressor genes by modulating epigenetic marks in human cervical cancer cellsJournal of Cellular Biochemistry, 2019
- Quercetin induces cell death in cervical cancer by reducing O-GlcNAcylation of adenosine monophosphate-activated protein kinaseAnatomy & Cell Biology, 2018